The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 61 articles
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial
Banning A,
Sabaté M,
Orban M,
Gracey J,
López-Sobrino T,
Massberg S,
Kastrati A,
Bogaerts K,
Adriaenssens T,
Berry C,
Erglis A,
Haine S,
Myrmel T,
Patel S,
Buera I,
Sionis A,
Vilalta V,
Yusuff H,
Vrints C,
Adlam D,
Flather M,
Gershlick A
August 21, 2023 | 10.4244/EIJ-D-23-00204
Clinical outcomes following different stenting techniques for coronary bifurcation lesions: a systematic review and network meta-analysis of randomised controlled trials
Bujak K,
Verardi FM,
Arevalos V,
Gabani R,
Spione F,
Rajwa P,
Milasinovic D,
Stankovic G,
Gasior M,
Sabaté M,
Brugaletta S
August 3, 2023 | 10.4244/EIJ-D-23-00013
Coronary calcification: you have to crack a few eggs to make an omelette
February 20, 2023 | 10.4244/EIJ-E-22-00053
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
August 5, 2022 | 10.4244/EIJ-D-21-00651
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial
Banning AS,
Adriaenssens T,
Berry C,
Bogaerts K,
Erglis A,
Distelmaier K,
Guagliumi G,
Haine S,
Kastrati A,
Massberg S,
Orban M,
Myrmel T,
Vuylsteke A,
Alfonso F,
Van de Werf F,
Verheugt F,
Flather M,
Sabaté M,
Vrints C,
Gershlick A
February 5, 2021 | 10.4244/EIJ-D-20-01076
Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion
Freixa X,
Cepas-Guillén P,
Flores-Umanzor E,
Regueiro A,
Sanchis L,
Fernandez-Valledor A,
Brugaletta S,
Carretero M,
Vidal B,
Masotti M,
Martin-Yuste V,
Roqué M,
Sitges M,
Sabaté M
February 5, 2021 | 10.4244/EIJ-D-20-00886
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial
Kandzari D,
Gershlick A,
Serruys PW,
Leon MB,
Morice M,
Simonton C,
Lembo N,
Mansour S,
Sabaté M,
Sabik J,
Kappetein A,
Dressler O,
Stone GW
December 18, 2020 | 10.4244/EIJ-D-19-00686
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Hara H,
Gao C,
Kogame N,
Ono M,
Kawashima H,
Wang R,
Morel M,
O'Leary N,
Sharif F,
Möllmann H,
Reiber J,
Sabaté M,
Zaman A,
Wijns W,
Onuma Y,
Serruys PW
December 18, 2020 | 10.4244/EIJ-D-20-00772
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys PW
December 4, 2020 | 10.4244/EIJ-D-20-00024
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial
Gomez-Lara J,
Salvatella N,
Romaguera R,
Brugaletta S,
Nato M,
Roura G,
Ferreiro J,
Teruel L,
Gracida M,
Sabaté M,
Vaquerizo B,
Cequier A,
Gomez-Hospital J
June 12, 2020 | 10.4244/EIJ-D-18-01203
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg G,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys PW
April 3, 2020 | 10.4244/EIJ-D-19-00699
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Munzel T,
Cequier A,
Buono A,
Serruys PW,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S,
Katagiri Y,
Byrne RA,
Brugaletta S,
Alfonso F,
Räber L,
Maeng M,
Iñiguez A,
Kretov E,
Onuma Y,
Joner M,
Sabaté M,
Laugwitz K,
Windecker S,
Kastrati A,
Serruys PW
March 20, 2020 | 10.4244/EIJ-D-18-01080
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys PW
August 9, 2019 | 10.4244/EIJ-D-19-00184
The art of educating a fellow: a “mother-and-child” relationship
May 20, 2019 | 10.4244/EIJV15I1A2
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study
Hioki H,
Brugaletta S,
Ishida K,
Campo G,
Biscaglia S,
Ortega-Paz L,
Cortese B,
Varricchio A,
Latib A,
Sabaté M,
Tespili M,
Ielasi A
May 20, 2019 | 10.4244/EIJ-D-18-00504
Latest news
AHEAD OF PRINT
Atherectomy in patients with lower extremity PAD
FREE ARTICLE - Mazen S. Albaghdadi et al
September 25, 2023
AHEAD OF PRINT
De-escalation from ticagrelor to clopidogrel in HBR patients
FREE ARTICLE - Min Chul Kim et al
September 19, 2023
NEW ISSUE
State-of-the-Art on Cerebral Embolic Protection; Debating Guided DAPT; 3-Year Outcomes of the EuroCTO Trial; the Myval Device in Non-Calcified Aortic Regurgitation...
New Issue
September 18, 2023
AHEAD OF PRINT
OCT guidance for evaluation and treatment of the long-term consequences of inadequate ostial left circumflex stenting
Free ARTICLE - Dejan Milasinovic et al
September 7, 2023
AHEAD OF PRINT
DCB in large coronary arteries
FREE ARTICLE - Pier Pasquale Leone et al
September 5, 2023
AHEAD OF PRINT
Rationale and design of the DEDICATE-DZHK6 Trial
FREE ARTICLE - Moritz Seiffert et al
September 1, 2023
AHEAD OF PRINT
DWP for TMVR
FREE ARTICLE - Clément Servoz et al
August 29, 2023